December 23, 2008 – The FDA approved for marketing EPIX Pharmaceuticals’ novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.

December 23, 2008 – The Society of Nuclear Medicine (SNM) will hold its annual Mid-Winter Educational Symposium February 5-8 at the Hilton Clearwater in Clearwater, FL.

December 23, 2008 - St. Jude Medical Inc. and MediGuide Inc. today signed a definitive merger agreement where MediGuide will become part of the St. Jude Medical Atrial Fibrillation Division.

December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB for $250 million in cash.

December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement to acquire Axsun Technologies Inc., a privately-held company that is a developer and manufacturer of lasers and optical engines used in medical optical coherence tomography (OCT) imaging systems and advan

December 22, 2008 - C. R. Bard Inc. recently received FDA clearance to market the E-Luminexx Vascular Stent - a flexible, self-expanding nitinol stent.

December 22, 2008 - W. L. Gore & Associates last week said Rush University Medical Center in Chicago is the first medical center to enroll a patient in the Gore REDUCE Clinical Study using the percutaneous GORE HELEX Septal Occluder to close patent foramen ovale (PFO).

December 22, 2008 - Edwards Lifesciences Corp. recently said it expects to drive sales growth and profitability in 2009 and beyond.

During its 2008 investor conference in New York City Dec. 11, Edwards' management presented details of the company’s growth plans, market expansion opportunities and its financial outlook for 2009.

December 22, 2008 - ZOLL Medical Corp. recently said more than 12,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the ZOLL LifeVest Wearable Defibrillator by their physician since it was approved by the FDA in 2002.

The company said this represents more than 2,000 years of cumulative patient time wearing a LifeVest, and, in any given month, more than 1,000 patients are being protected from sudden death wearing the LifeVest, Zoll said.

December 22, 2008 – Digisonics recently made several new installations of its DigiView CVIS for cardiovascular image analysis and reporting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now